Chinese Journal of New Drugs 2012 Issue 17 juan shou yu

juan shou yu
sun yan

..............page:1948-1949

Phase I study of anti-CD52 monoclonal antibody as treatment for patients with relapsed or refractory chronic lymphocytic leukemia and peripheral T cell lymphoma
ZHENG Wen;FU Zhi-ying;TU Mei-feng;LIN Ning-jing;LIU Wei-ping;XIE Yan;WANG Xiao-pei; SONG Yu-qin;PING Ling-yan;YING Zhi-tao;DENG Li-juan;ZHANG Chen;ZHU Jun

..............page:2041-2046

Vandetanib,a new drug for the treatment of medullary thyroid cancer
ZHU Ye;LONG Xu-mei;ZHANG Jian-ping;DU Hai-zhou

..............page:1959-1964

Progress in drug treatment for advanced pancreatic carcinoma
GONG Xin-lei;QIN Shu-kui

..............page:1992-2003

Current research status of dermal toxicity related to epidermal growth factor receptor tyrosine kinase inhibitors
GUO Fang;XIE Xiao-dong

..............page:2086-2090

Determination of WF-208 and its related substances by RP-HPLC
CUI Hong-xia;HUO Yan-shuang;LI Qing;LI Wei;WANG Man-man;CHEN Xiao-hui;BI Kai-shun

..............page:2069-2071,2090

Protective effect of Compound Sophorae Injection on radiation proctitis
WEN Qiang;JIANG Xian-ming

..............page:2063-2064

Preparation of TATm-survivin (T34A) freeze-dried injection and its anti-tumor activity in vitro
ZHU Ling;SHI Lei;TANG Li-li;XU Yu-xin;ZHANG Yi;MA Xing-yuan

..............page:1969-1973

Risks of iron overload for patients with myelodysplastic syndrome and the efficacy of deferasirox
LIU Rong-rong

..............page:2038-2040,2046

Preparation and quality evaluation of natamycin nanoemulsion
RUI Xian;OUYANG Wu-qing;WU Jing-chao;SONG Bing;LIU Mei-xue;DONG Rui

..............page:2072-2076

Advance in clinical research of non-small cell lung cancer vaccines
YANG Lu-lu;WU Yi-long

..............page:1979-1984,1991

Pharmacoeconomic evaluation of gefitinib in the treatment of advanced non-small cell lung cancer
LI Hong-chao1;FAN Chang-sheng2;HUANG Xu-ming2

..............page:2077-2085

Intracellular signal transduction pathways and related inhibitors in pathogenesis of non-Hodgkin’s lymphoma
DING Ning;ZHU Jun

..............page:2029-2034

New trends of advanced non-small cell lung cancer therapy
SHI Yuan-kai;JIA Bo

..............page:1985-1991

bian zhe tui jian
yang qing

..............page:1951

Research progress in individualized treatment of metastatic colorectal cancer with EGFR-targeted drugs
LIU Xiao-jing;XU Jian-ming

..............page:2025-2028

ben zhuan kan ze ren fu zhu bian jian jie

..............page:1950

Prophylactic cranial irradiation for small cell lung cancer
FU Xiao-long

..............page:2009-2011

2012 nian zhong guo yao xue da hui zuo di shi er jie zhong guo yao shi zhou hui yi tong zhi

..............page:2064

Anatomic pathology evaluations of oxaliplatin for injection in comparison with oxaliplatin liposome in Beagle dogs
QU Zhe;LI Shan-shan;WANG San-long;YANG Yan-wei;ZHANG Di;Lü Jian-jun;LIN Zhi;LI Bo

..............page:1974-1978

Efficacy and toxicity of ecotinib and gefitinib in the treatment for 28 patients with non-small cell lung cancer who have failed previous chemotherapy
CHEN Jian-hua;LUO Yong-zhong;WANG Wei;ZHOU Wen-wei;WEN Xiao-ping

..............page:2056-2059

shi jie xin yao zhi chuang

..............page:1953-1954

Synthesis of antitumor drug brivanib
SUN Min1;2;ZONG Zai-wei1;SUN Huan-liang1

..............page:2065-2068

Efficacy of Compound Sophorae Injection combined with FOLFOX7 chemotherapy in patients with colon cancer
WANG Jia-ming1;REN Hong-mei2

..............page:2060-2062,2068

When should first-line imatinib treatment of CML-CP patients switch to second-generation TKI
WANG Heng-xiang

..............page:2035-2037

Safety,toleration and therapeutic effect of the new drug icotinib hydrochloride in treating Chinese patients with non-small cell lung cancers
ZHANG Li1;REN Guan-jun2

..............page:2051-2055

Resistance mechanisms and treatment strategy of epidermal growth factor receptor tyrosine kinase inhibitors
ZHANG Hui;ZHANG Shu-cai

..............page:2012-2018

Research approach for registration of classification 3 chemical drugs
ZHANG Ning;CHEN Xiao-yuan

..............page:1965-1968

Pharmacology and clinical research of the new drug ipilimumab for treating advanced melanoma
SUN Shuang-yong1;2;PU Xiao-ping1;2

..............page:1955-1958

Exploration of translational research on small cell lung cancer
CHENG Ying;LIU Jing-jing

..............page:2004-2008,2085

New targets and therapeutic advance in non-small cell lung cancer beyond epidermal growth factor receptor
LI Xiao-yan;LIU Xiao-qing

..............page:2019-2024

Efficacy and safety of chemotherapy combined with Jinshuixian Capsules in treating 91 patients with lung cancer
LIN Hong-sheng1;LI Pei-wen2;WANG Xiao-min3

..............page:2047-2050,2055